4.8 Article

Artificial intelligence-assisted colorimetric lateral flow immunoassay for sensitive and quantitative detection of COVID-19 neutralizing antibody

Related references

Note: Only part of the references are listed.
Editorial Material Biochemistry & Molecular Biology

Omicron's message on vaccines: Boosting begets breadth

Duane R. Wesemann

Summary: Three studies in this issue of Cell confirm that SARS-CoV-2 Omicron effectively evades key immune defense-neutralizing antibodies. However, one or two doses of vaccine fail to induce anti-Omicron neutralizing antibodies, whereas a homologous third-dose booster restores neutralization function to some extent, highlighting the adaptability of immune memory to extend antibody reach across SARS-CoV-2 variants.
Article Biophysics

Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease

Aldo Roda et al.

Summary: The study developed a noninvasive and highly sensitive immunosensor for IgA in saliva and serum, which can be used for diagnosing and monitoring COVID-19 infection. The immunosensor demonstrated the capability to detect salivary IgA in infected individuals and correlated with disease severity and infection time.

BIOSENSORS & BIOELECTRONICS (2021)

Article Virology

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

Hideki Tani et al.

Summary: An alternative assay was developed to measure SARS-CoV-2 neutralizing antibodies, and a new chemiluminescence reduction neutralization test (CRNT) was found to be highly specific and sensitive for evaluating the occurrence of neutralizing antibodies against SARS-CoV-2 in a BSL-2 laboratory.

VIROLOGY JOURNAL (2021)

Article Chemistry, Multidisciplinary

Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis

Yilin Liu et al.

Summary: LFAs, paper-based point-of-care diagnostic tools, have traditionally lower sensitivities and specificities than standard laboratory tests. Recent efforts have focused on optimizing assay kinetics, signal amplification, and sample preamplification to increase sensitivities, as well as improving specificity through high-affinity molecules and assay optimization. With continuing improvements, LFAs may soon offer performance competitive with laboratory techniques while retaining a rapid format.

ACS NANO (2021)

Article Biochemistry & Molecular Biology

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng et al.

Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.

NATURE MEDICINE (2021)

Article Biochemical Research Methods

Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies

Verena Kraehling et al.

Summary: The study developed an ELISA assay for detecting SARS-CoV-2 specific antibodies with high specificity, reproducibility, and sensitivity, showing good performance in monitoring antibody responses to the virus, including seroconversion and the presence of neutralizing antibodies. Comparisons with a commercial assay demonstrated the in-house ELISA's superior sensitivity, highlighting its potential in detecting SARS-CoV-2 infections.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Article Chemistry, Analytical

Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples

Haifeng Liu et al.

Summary: This study reported a surface-enhanced Raman scattering-based lateral flow immunoassay method for the high sensitivity simultaneous detection of anti-SARS-CoV-2 IgM/IgG. The method utilized custom SERS tags and dual layers of Raman dye, with signal intensities easily recorded by a portable Raman instrument for high sensitivity analysis. Validation on samples from COVID-19 patients and healthy individuals showed high accuracy and specificity.

SENSORS AND ACTUATORS B-CHEMICAL (2021)

Article Chemistry, Multidisciplinary

Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape

Andre E. Nel et al.

Summary: Vaccination is crucial in controlling pandemics, with nanotechnology playing a significant role in vaccine development. Current vaccines have shown short-term efficacy and safety, but key issues include vaccine durability and adaptability against viral variants.

ACS NANO (2021)

Review Immunology

A comparative review of immunoassays for COVID-19 detection

Elham Mohit et al.

Summary: Serology testing has been considered as a valuable tool in diagnosing COVID-19, especially for RT-PCR negative individuals. Different serological methods, such as ELISAs, CLIAs, and LFIAs, were compared for their diagnostic performance. Results showed that higher sensitivity could be achieved by determining combined IgG/IgM titers and targeting spike (S) antigen for neutralization antibody detection. Additionally, ELISA/CLIA-based methods were found to have higher sensitivity compared to LFIA devices.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Editorial Material Immunology

Herd Immunity: The Journey Is as Important as the Destination COMMENT

Penny M. Heaton

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Chemistry, Multidisciplinary

Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses

F. Javier Ibarrondo et al.

Summary: Studies on two SARS-CoV-2 mRNA vaccines have shown that they provide about 95% protection from symptomatic infection in the short term, but questions remain about the comparison and stability of vaccine-induced antibody levels to natural infection. Antibody levels decline similarly after vaccination and natural infection, indicating potential need for booster shots.

ACS NANO (2021)

Article Infectious Diseases

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

Tal Brosh-Nissimov et al.

Summary: A study in Israel showed that a minority of fully vaccinated individuals with significant comorbidities may still develop severe COVID-19, with a high mortality rate. Further research on this vulnerable population may help improve their protection.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Medicine, General & Internal

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman et al.

Summary: The study shows that an extended interval before the second dose of the AstraZeneca vaccine leads to increased antibody titres, while a third dose significantly boosts antibody levels and enhances T-cell responses.

LANCET (2021)

Article Biochemistry & Molecular Biology

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

Emma Pritchard et al.

Summary: Results from the Office for National Statistics COVID-19 Infection Survey in the UK demonstrate that the ChAdOx1 nCoV-19 and BNT162b2 vaccines reduce the incidence of new SARS-CoV-2 infections by up to 65% with a single dose and up to 80% after two doses, with no significant differences in efficacy observed between the two vaccines.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

Review Chemistry, Physical

Polydopamine - its Prolific Use as Catalyst and Support Material

Arpad Molnar

CHEMCATCHEM (2020)

Article Biophysics

Photothermal enhancement in sensitivity of lateral flow assays for detection of E-coli O157:H7

Vahid Shirshahi et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Chemistry, Multidisciplinary

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

Young Hun Chung et al.

ACS NANO (2020)

Article Multidisciplinary Sciences

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Antonio E. Muruato et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

COVID-19: Coronavirus Vaccine Development Updates

Jing Zhao et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Mussel-inspired surface chemistry for multifunctional coatings

Haeshin Lee et al.

SCIENCE (2007)

Review Cell Biology

The physical and chemical properties of eumelanin

Paul Meredith et al.

PIGMENT CELL RESEARCH (2006)

Article Chemistry, Physical

Silica-coating and hydrophobation of CTAB-stabilized gold nanorods

Isabel Pastoriza-Santos et al.

CHEMISTRY OF MATERIALS (2006)